All News

Are we failing to be as efficient as we could be in delivering care to cancer patients, particularly in follow-up after treatment?

Do you know the median survival of different risk groups for patients with multiple myeloma? How about the recommended frequency to observe patients with smoldering myeloma? Test your knowledge on these topics and more in our latest quiz.

The antioxidant sodium thiosulfate protects children and adolescents against cisplatin-induced hearing loss without any added serious adverse effects, according to a randomized study.

Here, we discuss the etiologies, prevention, and management of cardiac toxicities in cancer survivors, considering cancer-related, treatment-related, and patient-related risks and effects. Programs in place to address cardiovascular risk factors in cancer survivors are highlighted.

In this Medical News Minute developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses recently published research that looks at quality of life outcome measures for elderly breast cancer patients who receive adjuvant chemotherapy.

In this Medical News Minute developed exclusively for Cancer Network, Dr. Bobby Lazzara expands on the question of whether statin therapy for breast cancer patients can lower the risk of recurrence and extend relapse-free survival.

Reducing the use of indoor tanning by enforcing an age restriction could potentially reduce melanoma incidence, mortality, and the costs associated with treating the disease, according to results of an economic analysis.

Do you know what minimum SPF strength has been shown to reduce melanoma risk? How about some of the differences between de novo melanomas and nevus-associated melanomas? Test your knowledge on these topics and more in our latest quiz.

This slide show highlights 2016 FDA approvals of cancer treatments, which to date include therapies for RCC, neuroendocrine tumors, Hodgkin lymphoma, CLL, sarcoma, bladder cancer, lung cancer, and breast cancer.

Gentle reader, the hour is late. As the poet said, almost all of the grains of sand allotted to 2016 have sifted down onto the pyramid of memory. Before this year’s hourglass empties, though, let’s take a moment to reflect on some of the phenomena we observed during the past months in this esoteric branch of medicine.

In patients with HER2-positive breast cancer undergoing trastuzumab therapy, the use of an ACE inhibitor or beta-blocker could protect against cardiac toxicity.

Do you know the latest on the 24-gene Post-Operative Radiation Therapy Outcomes Score for patients with prostate cancer? How about the important risk factors for prostate cancer incidence?

The use of radiotherapy was associated with an overall survival benefit in patients with prostate cancer and lymph node involvement who underwent radical prostatectomy and were also treated with androgen-deprivation therapy.

Computer analysis of subvisual data extracted from routine clinical MRI exams outperforms human experts at differentiating brain tumor recurrence from radiation necrosis.

We review here the recommendations of the American Society of Clinical Oncology, as well as some new and promising approaches to neuropathy, including new neuromodulation techniques.

Chemotherapy-induced peripheral neuropathy is a serious yet common side effect of cancer treatment. This devastating complication, which typically manifests as tingling and numbness in the hands and feet, has an enormous influence on patients’ quality of life.

Although melanoma represents less than 5% of skin cancers, it results in the most deaths. In the United States this year an estimated 76,380 new cases of melanoma will be diagnosed, and 10,130 people will die of the disease. Test your knowledge of melanoma risk factors, diagnosis, and treatment in our latest quiz.

This Medical News Minute examines a study that found that despite improving outcomes in breast cancer, outcomes among black patients still lag in comparison to white patients.

The American Academy of Family Physicians, American Cancer Society, ACOG, and the US Preventive Services Task Force each have published guidelines for breast cancer screening. Do you know the areas in which they differ?

Despite evolution of treatments and substantial improvements in survival, the self-reported health status among adult survivors of childhood cancers has not improved over 3 decades.

This Medical News Minute examines a recent study that compared two payment models, fee-for-service vs bundled payment, to see if there was any effect on breast cancer outcomes.

Stratifying breast cancer patients by chemotherapy and genetic susceptibility, researchers were able to identify patients at high risk of venous thromboembolism.

A recent retrospective study found that adding chemotherapy to postoperative treatment of craniospinal radiation for adults with medulloblastoma improves survival.

A cognitive rehabilitation program known as Insight resulted in improvements in cognitive symptoms compared to standard care in adult cancer survivors.

Do you know the ASCO guidelines for metastatic castration-resistant prostate cancer? How about prostate cancer incidence in various countries? Test your knowledge on these topics and more in our latest quiz.

Treatment at a facility with a higher patient volume was associated with a lower risk of mortality for patients with multiple myeloma, even after adjustment for sociodemographic and geographic factors and comorbidities.

Cancer survivors in the United States were taking medications to treat depression and anxiety at almost twice the rate of the general population between 2010 and 2013.

A new study showed that a 24-gene signature can predict outcomes following postoperative radiotherapy in patients with prostate adenocarcinoma who underwent radical prostatectomy.

This Medical News Minute examines a recent report that found that chronic infection with hepatitis B or C virus was associated with an increased risk for lymphoma among HIV patients on antiretroviral therapy.

This Medical News Minute outlines efforts by a number of advocacy groups and medical associations urging the CMS to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.